Shapeways (NYSE:SHPW – Get Rating) and Conversion Labs (OTCMKTS:CVLBD – Get Rating) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.
Insider and Institutional Ownership
25.3% of Shapeways shares are held by institutional investors. Comparatively, 0.3% of Conversion Labs shares are held by institutional investors. 29.3% of Shapeways shares are held by company insiders. Comparatively, 41.9% of Conversion Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Get
Shapeways alerts:
Valuation & Earnings
This table compares Shapeways and Conversion Labs' top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Shapeways | $33.62 million | 0.82 | $1.76 million | ($0.28) | -2.01 |
| Conversion Labs | $12.47 million | 7.49 | -$3.14 million | N/A | N/A |
Shapeways has higher revenue and earnings than Conversion Labs.
Analyst Recommendations
This is a summary of current ratings for Shapeways and Conversion Labs, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Shapeways | 0 | 0 | 1 | 0 | 3.00 |
| Conversion Labs | 0 | 0 | 0 | 0 | N/A |
Shapeways presently has a consensus target price of $3.19, suggesting a potential upside of 466.06%. Given Shapeways' higher probable upside, research analysts plainly believe Shapeways is more favorable than Conversion Labs.
Profitability
This table compares Shapeways and Conversion Labs' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
| Shapeways | -47.77% | -23.43% | -20.81% |
| Conversion Labs | -35.92% | N/A | -260.09% |
Risk & Volatility
Shapeways has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Conversion Labs has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.
Summary
Shapeways beats Conversion Labs on 7 of the 12 factors compared between the two stocks.
About Shapeways
(Get Rating)
Shapeways Holdings, Inc. facilitates the design, manufacture, and sale of 3D printed products in the United States, Europe, and internationally. The company offers an end-to-end digital manufacturing platform on which the users can transform digital designs into physical products under the Otto brand. It provides additive manufacturing services, such as 3D printing, rapid prototyping, and design services; and traditional manufacturing services, including injection molding, sheet metal, urethane and vacuum casting, CNC machining, and machine tooling. It also offers selective laser sintering materials, which include nylon 12, thermoplastic polyurethane, nylon 11, nylon 6 mineral filled, and polypropylene; binder jetting materials consisting of stainless steel and sandstone; multi-jet fusion materials; stereolithography materials, such as accura 60, accura xtreme, and accura xtreme white 200; selective laser melting material, including aluminum; material jetting materials, such as fine detail plastic, multi-color polyjet, and high definition full color; and wax casting materials comprising copper, platinum, gold, silver, bronze, brass, rhodium plated brass, and gold plated brass. The company serves the medical, consumer, robotics, architecture, aerospace, gaming, drones, education, and jewelry industries. Shapeways Holdings, Inc. was founded in 2008 and is based in Long Island City, New York.
About Conversion Labs
(Get Rating)
Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.
Receive News & Ratings for Shapeways Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shapeways and related companies with MarketBeat.com's FREE daily email newsletter.
